Revolutionizing Immunology with Oral Medicines Nello Mainolfi, PhD, Founder, President & CEO Kymera Therapeutics J.P. Morgan Healthcare Conference | January 2026 Patient-first mentality, with urgency: Rapidly advancing first-in-industry oral degraders with biologics-like activity Forward Looking Statements Defining and surpassing clinical benchmarks: Demonstrated compelling clinical translation of degraders' impact on clinical endpoints This presentation contains forward-looking statements within the meanin ...